DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Nucleus Software Exports Limited — Outcome of Board Meeting

NSE 1 hr ago·31 Oct 2026, 10:29 am

Nucleus Software Exports

Nucleus Software Exports Limited has informed the stock exchanges regarding its financial results for the period ending September 30, 2026. This disclosure is a routine corporate governance requirement that ensures transparency about the company's current performance and operational status.

For investors, this update is significant as it provides the latest data on the company's financial health, including revenue, profitability, and cash flow. Analyzing these figures helps retail investors assess the company's growth trajectory and operational efficiency against market expectations.

Investors should watch for specific details within the report, such as quarter-on-quarter growth in key segments and any commentary on future business outlook. This information is crucial for making informed decisions about the stock's short-term and long-term potential.